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Purpose: Skin prick testing (SPT) is fundamental to the practice of clinical allergy identifying
relevant allergens and predicting the clinical expression of disease. Wheal sizes on SPT are
used to identify atopic cases, and the cut-off value for a positive test is commonly set at 3 mm.
However, the measured wheal sizes do not solely reflect the magnitude of skin reaction to
allergens, but also skin reactivity (reflected in the size of histamine reaction) and other random
or non-random factors. We sought to estimate wheal sizes exclusively due to skin response to
allergens and propose gender-specific cutoff points of atopy.
Methods: We developed a Bayesian method to adjust observed wheal sizes by excluding
histamine and other factor effects, based on which revised cutoff points are proposed for males
and females, respectively. The method is then applied to and intensively evaluated using a study
population aged 18, at a location on the Isle of Wight in the United Kingdom. To evaluate the
proposed approach, two sample t-tests for population means and proportion tests are applied.
Results: Four common aeroallergens, house dust mite (HDM), grass pollen, dog dander, and
alternaria are considered in the study. Based on 3 mm cutoff, males tend to be more atopic
than females (P-values are between 0.00087 and 0.062). After applying the proposed methods
to adjust wheal sizes, our findings suggest that misclassifications of atopy occur more often in
males. Revised allergen-specific cutoff values are proposed for each gender.
Conclusion: To reduce the gender discrepancy, we may have two potentially convenient solutions. One way is to apply allergen-specific and gender-specific cutoff values following the
proposed method. Alternatively, we can revise the concentration of allergens in the SPT solutions
but keep the cutoff values unchanged, which may be more convenient to clinicians.
Keywords: SPT, atopy, Bayesian method, joint modeling, misclassification
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Atopy is regarded as an inherited predisposition for diseases such as eczema, asthma,
or rhinitis. Skin prick testing (SPT) to allergens is commonly used to identify allergic
sensitization or atopy. Although some previous studies have suggested different
cutoff values,1,2 in clinical practice, a 3 millimeter (mm) cutoff wheal size on SPT is
the criterion generally used to define a positive response and, therefore, sensitization.
An atopic status is defined as the presence of sensitization to one or more allergens
using this cutoff.
The present work is motivated by a discrepancy observed in our birth cohort
between atopy and atopy-related diseases such as eczema. The cohort was established between 1989 and 1990 on the Isle of Wight (IOW) in the United Kingdom to
prospectively study the natural history of allergic disorders. Skin prick testing was
performed on most participants attending the research center to a standard battery of
International Journal of General Medicine 2011:4 597–606
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common allergens (ALK, Horsholm, Denmark), including
aeroaller-gens (house dust mite, cat dander, dog dander,
Alternaria, Cladosporium herbarium, grass pollen mix, and
tree pollen mix) and food allergens (cows’ milk, soya, hens’
egg, peanut, and cod). In this work, we focus on individuals
aged 18, which includes 405 males and 445 females. Table 1
provides sensitization prevalence for four allergens, house
dust mite (HDM), grass pollen, dog dander, and Alternaria,
together with percentages of eczema among sensitized cases.
As shown in the table, with atopic status determined by the
3 mm cutoff, significantly more males are sensitized than
females based on two-sided two-sample proportion tests
(significance level is set at 0.01 after adjusting for multiple
testing). However, among the atopic children, the proportion of males who developed eczema tends to be lower than
(but not statistically significant based on the same type
of tests) that of females, although more males are atopic.
For instance, about 35% of males are sensitized to HDM,
which is significantly higher than that of females (23.37%).
However, among the atopic males, about 14% developed
eczema, which is lower than that of females (21.15%).
We also examined the other two allergic diseases, asthma
and rhinitis. Comparable patterns are observed (results not
shown). Although for allergen Alternaria, higher proportions of atopic males developed asthma and/or rhinitis, the
differences are statistically insignificant. These observations
(more atopic males but fewer with allergic diseases) conflict
with the well-established positive association between atopy
and atopy related diseases such as eczema and asthma.3–5
These observed discrepancies made us wonder whether
atopic status was misclassified.
To examine the existence of atopy misclassification, we
first compared total immunoglobulin E (IgE) between gender
in our cohort. The result shows insignificant difference
between males and females (the average total IgE for males is
296.0 ng/ml vs 287.4 ng/ml for females; P-value = 0.23 from
two-sided two sample t-test for population means), which

agrees with findings in other studies.6 In addition, results
from another cohort7 along with findings from other studies
examining the agreement of atopic status determined by SPT
and by specific IgEs reached the same conclusion8. That is,
insignificant differences of atopy prevalence exist between
gender based on specific IgEs but significant differences are
found based on SPT. Specific IgEs and total IgE are antibody
classes regarded as an important factor in the pathogenesis
of allergic diseases and higher IgE measures indicate higher
probabilities of allergic sensitization. This implies that we
ought to expect insignificant gender difference in atopy in
general populations. This conflicts with our findings on
SPT testing results and consequently indicates the possible
existence of misclassifications from SPT.
Since skin reactivity plays a role in the determination of
wheal sizes and this reactivity, reflected in histamine wheal
size, varies between gender at any given age,1,9–11 cutoff points
determined based on SPT wheal sizes without adjustment for
these factors may not correctly identify allergic sensitization
or determine atopic status. Thus to reduce the possibility of
misclassification, two venues may be taken: adjusting the
wheal sizes or proposing revised cutoff values that are genderspecific. Both directions aim to correct misclassifications,
specifically non-differential misclassifications (misclassifications independent from disease or exposure status).
Non-differential misclassifications can cause misleading
inferences if left unchecked. In linear or logistic regressions,
such errors may lead to biased estimates of coefficients.12–14
In many situations, the misclassifications are actually caused
by mismeasured continuous variables.15 This can be the situation of SPT wheal size measures in the sense that they are
not exclusively a result of allergen reaction; skin reactivity
also contributes to the size of a wheal.
In this article, through a Bayesian hierarchical joint
modeling, we first infer wheal sizes in response exclusively
to allergens, and then propose gender specific cutoff values
for sensitization. The utilization of the Bayesian method was

Table 1 Comparison between gender of atopy prevalence and percentage of atopic cases having eczema based on 3 mm cutoff (405
males and 445 females)
Allergen

Sensitization prevalence (%)

HDM
Grass
Dog dander
Alternaria
All above

% of atopic cases with eczema

Males

Females

P-value

Males

Females

P-value

35.06
26.73
12.35
9.63
46.53

23.37
21.34
8.99
6.74
34.61

0.00087
0.033
0.056
0.062
0.00013

14.08 (142)
13.89 (108)
26.00 (50)
17.95 (39)
12.23 (188)

21.15 (104)
18.95 (97)
25.00 (40)
20.00 (30)
20.13 (154)

0.073
0.16
0.46
0.41
0.023

Notes: The numbers of positive sensitization are included in the parentheses. Two-sided two sample proportion tests are used to test gender differences between
percentages for each allergen. For tests in columns 4 and 7, respectively, multiple testing adjusted significance level is 0.0125 (0.05/5 = 0.01) using the Bonferroni method.
P-values are listed to show the significance of percentage differences between gender.
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motivated by the hierarchical structure between atopy and
atopy related diseases. Due to the similar discrepancy patterns observed in asthma, eczema, and rhinitis, throughout
this article, we use eczema to demonstrate the method. In the
Discussion section, we briefly summarize results from the
other two allergic diseases. We focus on four common aeroallergens, HDM, grass pollen, dog dander, and Alternaria.
These four allergens are well represented in the IOW cohort
data. Other allergens are not considered due to the sparsity of
positive SPT reactions or their cross-reactivity with these four
allergens. We expect the work has the potential to resolve the
disagreement noted above, which will consequently improve
the diagnosis and management of allergic diseases.

interaction is denoted as Tij × Hij in model (1). The random
coefficients are assumed to be normally distributed with
2
β lij ~ N (0, σ β2l j) and β2ij ~ N (0, σ β2 j ). Note that genderspecific variances are assumed in the distributions of βlij and
β2ij. These flexible assumptions allow gender-specific effects
of histamine and its interaction with Tij, which were motivated by the findings from our cohort (at age 18, the average
histamine wheal size of males is 5.46 cm and of females is
5.09 cm; P-value = 0.00004 based on two-sided two sample
t-tests for population means). Finally, ∈ij explains unknown
random effects on Oij and is assumed to be normally distributed with mean zero and variance σ 12 .

The true wheal size

Material and methods
We start this section by presenting the modeling of observed
wheal sizes and that of the association between eczema and
wheal sizes in reaction to allergen (hereafter, true wheal
sizes). From the discussion above, the atopy prevalence
among males is expected to agree with atopy prevalence
among females in general populations, and there should not
exist gender differentiated association between true wheal
sizes and the risk of eczema.

In the following, we discuss the modeling separately for
observed wheal sizes, true wheal sizes, and the risk of
eczema. In the next section, they are linked through a joint
modeling process.

The observed wheal size
Let Oij denote the observed wheal size of person i with gender
j (j = 1 for females) in reaction to an allergen. The observed
wheal size is a mixture of response to the allergen, skin
reactivity and other unknown random factors. We use Tij to
denote the latent (unknown) true wheal size. The difference
between the expected value of Oij and Tij, denoted as Fij, is
modeled as a function of histamine effects (which reflects
skin reactivity) and possible interaction effects between the
allergen and histamine. We formulate them as follows:
Oij = Tij + Fij + ∈ij
(1)

where αj denotes an overall gender effect on the observed
wheal sizes and a constraint α1 + α2 = 0 is applied to avoid
singularity, βlij is a random slope for the contribution of histamine Hij, and β2ij is treated as being random as well indicating
an interaction effect between allergen and histamine. The
International Journal of General Medicine 2011:4

Tij = ϒ  + δij,

(2)

in which ϒ denotes what we expect on wheal sizes for a
general population in reaction to an allergen, regardless of
gender. The second term δij is for random errors. It represents
possible differentiated reaction to the allergen at an individual
level. We assume δij is half-normally distributed, that is,

δ ij ~ Half − N (0, σ 22 ),

Model construction

Fij = αi + βlij Hij + β2ijTij × Hij,

The latent variable Tij in (1) represents wheal sizes in reaction
to an allergen (the true wheal size). We model Tij as

where zero and σ 22 denote the mean and variance in the
corresponding normal distribution function. The density of
the half-normal distribution defined above is in a shape of a
half bell-curve starting at zero. This distribution function is
utilized to reflect the fact that most subjects are non-atopic.
Besides the half normal distribution, other skew distributions can be possibly applied, for instance, the skew normal
distribution.16,17
The message conveyed by model (2) is that the wheal sizes
of males and females are expected a priori to follow the same
distribution. However, if Fij and ∈ij in (1) are not sufficient
to explain gender discrepancy, the skew-distributed random
error δij can still possibly differentiate males’ and females’
true wheal sizes. In this case, data for different genders are
likely to be generated from different parts of a half-normal
distribution.

The association between eczema and atopy
Since atopy is considered as a risk factor of eczema, modeling
the association between true wheal sizes (Tij) and eczema
seems a reasonable instrument in the process of identifying
misclassifications. A logistic regression given below is
considered:
submit your manuscript | www.dovepress.com
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logit(P(Yij = 1)|Tij) = η0 + τj + η1Tij,

(3)

where Yij takes values 1 or 0 denoting the status of eczema.
Equation (3) evaluates gender effect τj (assuming τ1 + τ2 = 0
to avoid singularity) and the effect of true wheal size (η1) to
the odds of eczema.

Statistical analysis
We consider a method of joint modeling to infer the true
wheal size. Joint modeling is appropriate for data sharing
features in common. It has been used in analysis of combined
longitudinal and survival data,18–20 random effects data,21
and mark-recapture data.22 The joint model in our analysis
is composed of two parts: the modeling of observed wheal
sizes and the modeling of association between the true wheal
size and the risk of eczema. The models presented in (1) to (3)
are linked to each other with Tij being the joint. We include
a brief structure of the joint model in Figure 1.
Let f(.) denote a generic density function. Equations (1)
to (3) induce a joint density of Yij, Oij, and Tij in a hierarchical
structure, which is
f (Yij, Oij, Tij) = P (Yij = 1|Tij, Oij) f (Oij|Tij) f (Tij)
= P (Yij = 1|Tij) f (Oij|Tij) f (Tij)

(4)

Here we suppress the dependence on the unknown
parameters for simplicity. The last equality is due to the
assumption that the observed wheal size does not provide
any additional information at the presence of true wheal size
(non-differentiable measurement errors). The advantage of
a joint analysis is that more sources of information can be
incorporated, and thus the inference on true wheal sizes is
expected to be more accurate. The joint model presented
in (4) allows us to infer Tij based on information from two
sources, the disease status Yij and observed wheal size Oij.
Inferences of Tij will be further used to facilitate the revision
of the 3 mm cutoff point.
L e t θ = {α j , σ β21 j, σ β22 j , σ 12 , σ 22 , γ , η0 , η1 , τ j } d e n o t e a
collection of parameters. The hierarchical structure shown

in (4) motivated us to utilize the Bayesian method to infer
the parameters and true wheal sizes Tij. Here we briefly
discuss the steps necessary to draw Bayesian inferences.
To be fully Bayesian, we assign prior distributions to each
parameter. Prior distributions of coefficients including αj, γ,
η0, η1 and τj are selected as vague normal distributions with
mean zero and large variances. Prior distributions of variance
components including σ β21 j, σ β22 j, σ 12 and σ 22 are assumed to
follow inverse gamma distributions with scale and shape
parameters being 0.5 and 0.0005, respectively.23 Once prior
distributions are specified, the joint posterior distribution
of the parameters can be formulated using equations (1) to
(4) in a hierarchical way. Next, we use the Markov Chain
Monte Carlo (MCMC) approach, specifically, the Gibbs
sampler to draw samples for each parameter and Tij from the
joint posterior distribution. The convergence of the MCMC
chains is examined using the method proposed in pervious
studies.24–26 The program is coded in WinBUGS.27 A detailed
graphical structure with all parameters included are given
in the Appendix (Figure 3) along with the corresponding
WinBUGS program (Figure 4).
o
Defining adjusting factor Fj and cutoff value C j

The proposed approach draws inferences on the true wheal
sizes Tij. In practice, clinicians or epidemiologists may be
more interested in handy cutoff values, which is practically
more meaningful. Based on posterior inferences of Tij and Fij,
we propose revised cutoff points C oj applied to Oij for males
and females, respectively. The revised cutoff value is defined

as C oj = 3 − F j according to (1), j = 1, 2, where the 3 mm is the

current cutoff value and F j denotes an estimate of adjusting
factor Fj. The adjusting factor can be estimated by taking the
means of posterior estimates of Fij for each gender; recall Fij
in (1) represents an adjustment to each individually observed
wheal size. It can also be estimated as the difference between

Oj and T j for gender j, where Oj is the mean of observed wheal

sizes Oij, T j is the estimate of mean true wheal size for gender
j and is calculated as the sample mean of the inferred true
wheal sizes Tij.

Examining the proposed method.
Gender

Histamine

X

Fij

True wheal
size (Tij)

Observed
wheal size (Oij)

Risk of
eczema (Yij = 1)

“ X “ denotes interaction.

Figure 1 Conceptual structure of the joint model.
Note: Squares represent constant (fixed) and ovals represent stochastic variables.
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To evaluate the insights brought in by Tij and C oj , we examine
if the discrepancy is reduced or eliminated between males’
and females’ prevalence in atopy and in eczema among atopic
cases. We apply two-sided two sample proportion tests to test
the difference between genders of atopy prevalence and of
eczema prevalence among atopic cases. We then compare the
results from Tij and C oj to those from Oij and the 3 mm cutoff
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value. We also evaluate the difference of Tj between genders,
and compare it with the difference of Oj between genders.
For this purpose, two-sided two sample t-tests applied to
population means are applied. For each type of test, the Bonferroni approach is used for multiple testing corrections. The
experiment-wise significance level is set at 0.05.

Results
Inferences of Tij and C oj

Using the proposed method, we infer Tij and the adjusting
factors for each of the four allergens (HDM, grass pollen,
dog dander, and Alternaria). Table 2 includes descriptive
statistics (mean and standard deviation) of Oij and Tij for each

gender, denoted as Oj and T j in the table, respectively. The
revised cutoff values C oj are presented in the last column of
the table. As shown in the table, overall the results are consistent across different allergens for each gender. For females,

T j agrees with Oj, and C oj agrees with the commonly used
3 mm cutoff point. However, this is not the case for males.

For males, T j ’s are all smaller than Oj’s and larger cutoff
values are suggested.
By comparing the differences of Oj between genders

and the differences of T j between genders, we can see that
the adjusting process clearly has the ability to reduce the
disagreement of wheal sizes between males and females. In
Table 2 Summary of observed and inferred wheal sizes and
proposed cutoff values (The unit of each variable is in millimeters.
Standard deviations are in the parentheses)
Gender
HDM
Males
Females
P-value
Grass
Males
Females
P-value
Dog dander
Males
Females
P-value
Alternaria
Males
Females
P-value

Oj

Tˆ j

Fˆj

Cj

2.08 (2.78)
1.36 (2.37)
0.000065

1.66 (0.98)
1.48 (0.97)
0.0061

-0.43
0.10

3.43
2.90

1.80 (3.03)
1.23 (2.36)
0.0023

1.33 (0.89)
1.25 (0.86)
0.14

-0.51
0.01

3.51
2.99

0.77 (1.54)
0.55 (1.27)
0.021

0.59 (0.36)
0.57 (0.35)
0.31

-0.18
0.02

3.18
2.98

0.61 (1.66)
0.39 (1.31)
0.036

0.39 (0.26)
0.38 (0.25)
0.42

-0.22
0.01

3.22
2.99

o

Notes: j = 1, 2 denotes two genders. Oj: the average of observed wheal sizes. Tˆj : the
o
average of inferred true wheal sizes. Fˆ : estimate of the adjusting factor C j is the revised
j
cutoff point. Two F sample t-tests were performed to test the differences of means
between gender. In columns 2 and 3, respectively, multiple testing adjusted significance
level is 0.0125 (0.05/4 = 0.0125) using the Bonferroni method. P-values are listed to
show the significance of mean difference of wheal sizes between genders.

International Journal of General Medicine 2011:4

particular, as indicated by the P-values, the disagreement of
wheal sizes between gender based on Tij is eliminated for
all allergens except for HDM. The significant differences
between genders for HDM implies that besides histamine
reactivity effect and its interaction with HDM, other unknown
but non-random factors may also contribute to the formation of discrepancy. Further studies are needed to identify
those possible factors. On the other hand, as indicated by the
reduction of P-values, although gender discrepancy is not
eliminated for HDM, the probability of observing such difference between males and females under the null hypothesis is
increased compared to that based on Oij. This implies that on
average the dissimilarity between males’ and females’ wheal
sizes is reduced based on the inferred true wheal sizes.
The inferences of Tij discussed so far are promising in that
gender discrepancy in wheal sizes is significantly reduced.
However, the reduction of disagreement in wheal sizes
does not necessarily lead to a discrepancy reduction in the
prevalence of sensitization to an allergen. This is examined
in the following section.

Prevalence comparison based on Tij

To compare sensitization prevalence between gender
using Tij (true wheal size), a cutoff value C tj applied to
Tij is needed. We use inferences related to grass pollen to
demonstrate the C tj selection process. Figure 2 plots the
prevalence of sensitization based on Tij versus different
cutoff values. The difference of prevalence between genders
decreases as the cutoff value increases, which implies the
importance of choosing an appropriate cutoff value. As
indicated in Table 2, the revised cutoff values for females
(the last column of Table 2) in general agrees with the commonly applied 3 mm cutoff point. Our paired tests further
indicate that Ti1 agrees with Oi1 in all the four allergens
(all P-values . 0.05. For this grass pollen example, the
P-value is 0.79). These results imply that for females the
sensitization prevalence based on Oi1 is expected to agree
with the prevalence based on Ti1. As discussed below, this
finding is then utilized to determine an atopy cutoff value
for Tij applied to both genders, since there is no significant
difference of Tij between genders.
The prevalence of atopy for females based on Oij is
21.34% as in Table 1. Given the agreement between Oi1 and
Ti1, we apply this prevalence to Tij resulting in a cutoff value
C tj = 1.97 mm. Using this cutoff value, the sensitization prevalence for males is 25.68% and for females is 21.80% (different
from 21.34% due to rounding errors), which are insignificantly
different from each other (P-value = 0.09). The same proce-

submit your manuscript | www.dovepress.com
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0.30

Males
0.25

(1.97, 0.2568)

Females

0.05

0.10

0.15

0.20

(1.97, 0.2180)

0.00

Sensitization prevalence for grass pollen

Zhang et al

2.0

2.5

3.0

3.5

Cutoff value
Figure 2 The relationship between sensitization prevalence of wheat and cutoff
value based on Tij.

Table 3 Cutoff values and sensitization prevalence comparison
between gender based on Tij
Allergen

Cutoff value
(mm)

Sensitization prevalence (%)
Males

Females

P-value

HDM
Grass
Dog dander
Alternaria

2.4
1.97
1.28
0.99

28.89
25.68
8.40
6.17

22.92
21.80
9.21
6.97

0.023
0.09
0.34
0.32

Notes: Two-sided two sample proportion tests are used to test gender differences
between percentage for each allergen. Multiple testing adjusted significance level
is 0.0125 (0.05/4) using the Bonferroni method. P-values are listed to show the
significance of prevalence differences between gender.

Table 4 Eczema cases with positive sensitization based on Tij
Allergen

% of atopic cases with eczema

HDM
Grass
Dog dander
Alternaria

Males

Females

P-value

16.24 (117)
13.72 (102)
41.18 (34)
16.00 (25)

22.55 (102)
19.59 (97)
29.26 (41)
19.35 (31)

0.12
0.13
0.14
0.37

dure is repeated for the remaining three allergens. The cutoff
values C tj and the comparison of sensitization prevalence
between genders are summarized in Table 3. After adjusting
for multiple testing using the Bonferroni method (multiple
testing adjusted significance level = 0.0125), the differences
of atopy prevalences between genders are no longer statistically significant for any single allergen. Utilizing information
summarized in Table 1, we then identified the individuals,
especially males, who are misclassified into the atopic group
by applying the 3 mm cutoff to the observed wheal sizes Oij.
Specifically, among 142 males originally classified into the
HDM sensitization group, 25 (17.61%) are misclassified;
results of misclassification for grass pollen, dog dander, and
Alternaria are 4 (3.70%) out of 108, 16 (32%) out of 50, and
14 (35.90%) out of 39, respectively.
So far our focus is on the prevalence of atopy. We now turn
to the comparison of eczema prevalence among atopic
cases. The results are given in Table 4. Comparing the
prevalence differences between genders, we can see that
the results of insignificant differences drawn from Oij
(see Table 1) are kept for Tij. This finding, coupled with
the findings on Tij-based atopy prevalence, demonstrates
the applicability of the proposed adjusting process. This
process has the potential to correct the bias in wheal
size measuring and resolve the conflict between atopy
prevalence and findings on eczema prevalence and IgE
measures.
In an early section, we proposed cutoff values C oj applied
to Oij. Even with the promising gain from inferring Tij, to
clinicians and epidemiologists, it is possibly more convenient
to use C oj . In the next section we examine if we can reach the
same conclusion on the elimination of gender discrepancy
by using C oj .

Prevalence comparison based on C oj

Notes: The numbers of positive sensitization are included in the parentheses.
Two-sided two sample proportion tests are used to test gender differences between
percentage for each allergen. Multiple testing adjusted significance level is 0.0125
(0.05/4) using the Bonferroni method. P-values are listed to show the significance of
percentage differences between gender.

We apply the revised cutoff value C oj given in Table 2 to the
observed wheal sizes to infer the prevalence of sensitization
and that of eczema among atopic cases. The results are presented in Table 5. Compared to the results given in Table 1,

Table 5 Comparison of prevalence between gender based on C oj of sensitization and percentage of atopic cases having eczema
Allergen

Sensitization prevalence (%)

HDM
Grass
Dog dander
Alternaria

Prevalence of eczema among atopic cases (%)

Males

Females

P-value

Males

Females

P-value

32.35
24.75
10.62
8.89

23.37
21.35
8.99
6.74

0.0017
0.12
0.21
0.12

15.27
14.00
27.91
19.44

21.15
18.95
25.00
20.00

0.12
0.18
0.38
0.47

Notes: Two-sided two sample proportion tests are used to test gender differences between percentages for each allergen. For tests in columns 4 and 7, respectively,
multiple testing adjusted significance level is 0.0125 (0.05/4 = 0.0125) using the Bonferroni method. P-values are listed to show the significance of percentage differences
between gender.
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Table 6 Comparison of prevalence between gender of atopy and percentage of atopic cases having eczema based on different cutoffs
on all allergens
Allergen

Sensitization prevalence (%)

Prevalence of eczema among atopic cases (%)

Males

Females

P-value

Males

Females

P-value

3 mm
(males and females)
3.5 mm (males),
3 mm (females)

47.89

35.36

0.00011

11.92

20.38

0.00010

45.91

35.36

0.00089

11.89

20.38

0.00023

Notes: Two-sided two sample proportion tests are used to test gender differences between percentages for each allergen. For tests in columns 4 and 7, respectively, multiple
testing adjusted significance level is 0.0125 (0.05/4 = 0.0125) using the Bonferroni method. P-values are listed to show the significance of percentage differences between
gender.

the updated prevalence differences between genders for
each allergen are less significant, although for HDM the
significant gender discrepancy still exists. The prevalence
of eczema among atopic cases is not significantly different
between males and females for each individual allergen, the
same trend as in Table 1.
By using although the gender discrepancy cannot be completely eliminated for all allergens and the results are not as
promising as those based on Tij (Tables 3 and 4), the revised
cutoff value C oj does have the potential to decrease the significance of gender discrepancy in sensitization prevalence.

Discussion
Motivated by the inconsistency between the wheal size-based
atopy prevalence in men and women and the results of IgE
measures, we developed a Bayesian method to estimate
true wheal sizes and proposed gender-specific sensitization
cutoff values for different allergens. The disease outcome
considered in this work is eczema. The allergens considered
are common aeroallergens including house dust mite, grass
pollen, dog dander, and Alternaria.
Based on inferred true wheal sizes (Tij), the differences
in sensitization prevalence between males and females are
statistically insignificant with respect to each individual allergen, and the chance that sensitized males developing eczema
is comparable to that of sensitized females. This indicates a
significant improvement compared to the results based on
observed wheal sizes with the 3 mm cutoff. On the other
hand, if we apply the revised cutoff values C oj to observed
wheal sizes (other than directly using inferred Tij), our results
showed limited improvement. It thus seems more reasonable
to adjust the observed wheal sizes than to revise the 3 mm
cutoff value for each allergen and gender. The findings can be
further assessed by calculating the sensitivity and specificity
with the help of gold standard such as radioallergosorbent
test proposed in early studies.28,29 We also applied the method
to two other allergic diseases, asthma and rhinitis. Similar
results are drawn for allergens HDM, grass pollen, and dog
International Journal of General Medicine 2011:4

dander. For Alternaria, results from the method suggest
adjusting wheal sizes is unnecessary.
On the other hand, since utilizing revised cutoff values
o
(C j ) does reduce the differences between males and females,
although the reduction is not significant in some situations,
one may wonder the possibility to propose cutoff values
separately for males and females but apply to all allergens. We
further investigated this possibility. Based on the results given
in Table 2, we used 3.5 mm cutoff for males and 3 mm cutoff
for females. These cutoff values are applied to all allergens.
However, as indicated by the results in Table 6, very limited
reduction in the statistical significance is observed. Similar
results are obtained when using other cutoff values different
from 3.5 mm. This finding indicates that just revising cutoff
points applied to all allergens may not at all solve the prevalence discrepancy between males and females. Instead, we
may have to deal with each individual allergen.

Conclusion
To correct misclassified atopic cases caused by gender
discrepancy, we can utilize the proposed statistical methods
to adjust wheal size measures. Besides adjusting observed
wheal sizes, we found that using allergen-specific cutoff
values different for men and women (C oj ) will also reduce
the occurrence of misclassifications.
Clinicians may prefer the same cutoff value applied to
all allergens. To achieve this goal and keep misclassification
reduced, a laboratory-related alternative solution may be
possible. Specifically, based on the inferred cutoff values
C oj , one can adjust the concentration of allergens used in
the prick test solutions for men and women, respectively.
The results from this work may assist the determination
of allergen concentration. This approach makes it possible
to reduce the gender discrepancy in atopy without revising cutoff values. Our work shows that future clinical,
mechanistic, and epidemiological studies are needed to
optimize the skin prick test to make it agree with results
from specific IgE levels.
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Dovepress

603

Zhang et al

Acknowledgment
This work was supported by the National Heart, Lung, and Blood
Institute at the National Institute of Health (5R01 HL082925,
PI: Arshad SH; 1R03HL095429, MPI: Zhang H).

Disclosure
The authors report no conflict of interest in this work.

References

1. Gergen P, Turkeltaub P, Kovar M. The prevalence of allergic skin test
reactivity to eight common aeroallergens in the US population: results
from the second national health and nutrition examination survey.
J Allergy Clin Immunol. 1987;80:669–679.
2. Chinn S, Jarvis D, Luczynska C, et al. Measuring atopy in a multi-centre
epidemiological study. European Journal of Epidemiology. 1996;12:
155–162.
3. Arshad S, Karmaus W, Matthews S, et al. Association of allergy related
symptoms with sensiti-sation to common allergens in an adult european
population. J Inves Allergology Clin Immunol. 2001;11:94–102.
4. Sly P, Boner A, Björksten B, et al.
5. Gergen P, Arbes S Jr, Calatroni A, et al. Total ige levels and asthma
prevalence in the us population: results from the national health
and nutrition examination survey 2005–2006. Journal of Allergy
and Clinical Immunology. 2009;124:447–453. doi:DOI: 10.1016/j.
jaci.2009.06.011.
6. Shoormasti R, Pourpak Z, Eshraghian M, et al. The study of total ige
reference range in healthy adults in tehran, iran. Iranian J Public Health.
2010;39:32–36.
7. Van Eerdewegh P, Little R, Dupuis J, et al. Association of the
adam33 gene with asthma and bronchial hyperresponsiveness. Nature.
2002;418:426–430.
8. Bousquet P, Castelli C, Daures J, et al. Assessment of allergen sensitization in a general population-based survey (european community
respiratory health survey i). Ann Epidemiol. 2010;20:797–803.
9. Barbee R, Lebowitz M, Thompson H, et al. Immediate skintest reactivity
in a general population sample. Ann Intern Med. 1976;84:129–133.
10. Peat J, Woolcock A. Sensitivity to common allergens: relation to
respiratory symptoms and bronchial hyper-responsiveness in children
from three different climatic areas of australia. Clin Exp Allergy.
1991;21:573–581.
11. Meinert R, Frischer T, Karmaus W, et al. Influence of skin prick test
criteria on estimation of prevalence and incidence of allergic sensitization in children. Allergy. 1994;49:526–532.

604

submit your manuscript | www.dovepress.com

Dovepress

Dovepress
12. Gustafson P. Measurement error and misclassification in statistics and
epidemiology: impacts and bayesian adjustments. Chapman and Hall/
CRC Press, Boca Raton, FL; 2003.
13. Bross I. Misclassif ication in 2×2 tables. Biometrics. 1954;10:
478–486.
14. Goldberg J. The effects of misclassification on the bias in the difference
between two proportions and the relative odds in the fourfold table.
Journal of the American Statistical Association. 1975;70:561–567.
15. Natarajan L. Regression calibration for dichotomized mismeasured
predictors. The International Journal of Biostatistics. 2009;5:
article 12.
16. Azzalini A. A class of distributions which includes the normal ones.
Scandinavian Journal of Statistics. 1985;12:171–178.
17. Azzalini A. Further results on a class of distributions which includes
the normal ones. Statistica (Bologna). 1986;46:199–208.
18. Ding J, Wang J. Modeling longitudinal data with nonparametric
multiplicative random effects jointly with survival data. Biometrics.
2008;64(2):546–556.
19. Henderson R, Diggle P, Dobson A. Joint modelling of longitudinal
measurements and event time data. Biostatistics (Oxford). 2000;1(4):
465–480.
20. Tsiatis A, Davidian M. Joint modeling of longitudinal and time-to-event
data: an overview. Statistica Sinica. 2004;14(3):809–834.
21. Bigelow J, Dunson D. Bayesian Semiparametric joint models for
functional predictors. Journal of the American Statistical Association.
2009;104(485):26–36.
22. Barker RJ. Joint modeling of live-recapture, tag-resight, and tagrecovery data. Biometrics. 1997;53:666–677.
23. Kelsall J, Wakefield J. Discussion of “Bayesian models for spatially
correlated disease and exposure data” by best et al. Bayesian Statistics.
1999;6:151.
24. Gelman A, Rubin BD. Inference from iterative simulation using multiple
sequences. Statistical Science. 1992;7:457–511.
25. Gelman A, Rubin DB. A single series from the Gibbs sampler provides
a false sense of security. In: Bernardo JM, Berger JO, Dawid AP,
et al, editors, Bayesian statistics 4 proceedings of the fourth valencia
international meeting. Clarendon Press: Oxford University Press;
625–631.
26. Gelman A, Carlin JB, Stern HS, et al. Bayesian Data Analysis. Chapman
and Hall/CRC; 2003.
27. Spiegelhalter D, Thomas A, Best N, et al. WinBUGS user manual.
MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK,
2003.
28. Dreborg S. Skin tests used for epidemiological studies. Allergy. 1989;44:
52–59.
29. Haahtela T. Skin tests used for epidemiologic studies. Allergy. 1993;48:
76–80.

International Journal of General Medicine 2011:4

Dovepress

Wheal size measurement and atopy misclassification

Appendix
The model structure
The structure in Figure 1 shows the formulation of the
Bayesian joint model including models (1) to (3) along
with the specified prior distributions. It is drawn using
D oodleBUGS. 29 Squares represent constant (f ixed),
ovals represent stochastic or unknown variables, hollow
(thicker) arrows are for logical functions (such as definitions or identities), and single arrows are for stochastic
dependencies (distributions involved). There are two

panels in the figure. The smaller panel indicated by “for
(i IN 1:n[j])” is for parameters and random variables
related to each individual, the ovals between the bigger
panel and the smaller one are for the parameters exclusively related to gender, and the ovals outside the two
panels are for common parameters.

The WinBUGS codes
The codes below are consistent with the structure given in
Figure 1.

gamma0

alpha[j]

prec2[j]

lambda

prec1[j]

tau[j]

eta0

eta1
alpha0

p[j,i]

T[j,i]

beta1[j,i]
beta2[j,i]

mu[j,i]
Status[j,i]
F[j,i]

Hist[j,i]

O[j,i]

prec0

for(i IN 1 : n[j])
for(j IN 1 : 2)
Appendix Figure 1 The detailed structure of the Bayesian joint model.
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{

for (j in 1:2) #j gender
{
for (i in 1: n[j])# in the observation
{
# logistic regression modeling the association between true wheal size
# and disease outcome (status)
status[j,i]~dbin(p[g,i],1)
logit(p[j,i])<-eta0+tau[j]+eta1*T[j,i]
# linear regression evaluating factor effects contributed to the observed
# wheal sizes
O[j,i]~dnorm(mu[j,i], precO)
F[j,i]<-alpha0+alpha[j]+beta1[j,i]*His t[j,i]+beta2[j,i]*Hist[j,i]*T[j,i]
mu[j,i]<- T[j,i]+F[j,i]
# half-normal distribution describing the distribution of true wheal size
T[j,i]~djl.dnorm.trunc(gamma0,lambda,gamma0,1000)
# prior distributions of the coefficients
beta1[j,i]~dnorm(0, prec1[j])
beta2[j,i]~dnorm(0, prec2[j])

}
# prior distribution for the precision parameters (inverse of variance) in the prior
# distributions of beta1 and beta2.
prec1[j]~dgamma(0.5, 0.5)
prec2[j]~dgamma(0.5, 0.5)

}
# prior distributions for the coefficients in the logistic regression
eta0~dnorm(0,0.01)
eta1~dnorm(0,0.01)
tau[1]~dnorm(0,0.01)
tau[2]<--1*delta[1]

# prior distributions for the precision parameter precO (inverse of the variance) in the
# distribution of O_ij, overall effect alpha0, and gender effects alpha_j, j=1,2.
precO~dgamma(0.5, 0.5)
alpha0~dnorm(0,0.01)
alpha[1]~dnorm(0,0.01)
alpha[2]<--1*alpha[1]

}

# prior distributions for the parameters in the half-normal distribution
gamma0~dgamma(0.5, 0.5)
lambda~dgamma(1,0.001)

Appendix Figure 2 The WinBUGS program corresponding model structure in Appendix Figure 1.
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